Tuesday, November 30, 2010

Do Natural Hormones cream and troches cause cancer? Xanya Sofra Weiss

Lara Grinevitch BSc, ND; 2007

These were the headlines in the media last month, and they were very misleading. There was never any suggestion that natural progesterone causes cancer. The concern about cancer is a concern about oestradiol (a strong oestrogen that is used in some, but not all, bio-identical hormone formulas). If a troche does contain oestradiol, then there is a risk for the breasts and the uterus. Natural progesterone offsets the risk for the breasts, but the conventional medical community in Australia argues that it does not protect the uterus. The Medical Journal of Australia put forward three cases of stage 1 endometrial cancer in women who had used oestradiol-containing troches. (1). (Stage 1 endometrial cancer is relatively mild, and is expected to have a good outcome.) No definitive proof is available that the troches had been the cause of the cancer. The women had been on the troches for 18 months, 3 years and 6 years. Yes, it is true that oestradiol supplements require progesterone to reduce the risk of endometrial cancer. Artificial progesterone, called progestin, was introduced as part of HRT in the 1960’s to do just that. It was a pharmaceutical band-aid for the epidemic of endometrial cancer that had resulted from conventional oestrogen HRT. Natural progesterone would have been the more logical choice at that time (because protecting the endometrium is one of progesterone’s normal jobs in the body). And natural progesterone would have had another benefit, had it become part of conventional HRT: Natural progesterone also protects against BREAST CANCER. (Progestins do the opposite: They INCREASE the risk for breast cancer.) The protective effect on the breasts is the main reason that natural health practitioners prefer natural progesterone to progestin.Although natural progesterone could have been the logical choice for endometrial cancer prevention all along, there were two reasons why it was not initially used: 1) At the time that Progestins were introduced (1960’s), natural progesterone was not available except by injection. 2) As a natural hormone, progesterone was not patentable. Today, technology allows progesterone to be absorbed through the skin or ingested. There is evidence that it is absorbed, and there is evidence that it does protect against endometrial cancer (2,3). In parts of Europe, ‘micronised progesterone’ (natural progesterone) has become standard care in gynaecology. The fact that it remains a fringe prescription in Australia is more to do with entrenched practice than medical science

Xanya Sofra Weiss

Xanya Sofra Weiss

The Secret of Hydrate2o Protons (H+) and Proton Donors. Xanya Sofra Weiss

First the basic facts:
1. Only hydrogen can create the free proton, H+. It is a law of the universe. Water contains protons that can be donated to a reaction. Water disassociates into H+ and OH-.
2. The presence of protons, H+ has everything to do with acidic pH measurements and oxidation- reduction potential measurements (ORP). If you measure an acidic pH and a positive ORP in pure water you have free protons.
3. For every electron involved in a reaction, a proton, H+ must be donated to the set of oxidation-reduction reactions to keep the system electrically balanced. That is a law of oxidation - reduction reactions. The Krebs cycle is nothing but coupled oxidation- reduction reactions. Protons drive the Krebs cycle.
4. The mitochondria and the Krebs cycle must have protons or your body can not produce energy and you die. It is called the proton motive force. Dr. Krebs won a noble prize for this discovery.
5. Proton Donors are nothing more complicated then being a source of protons to the mitochondria. Not all hydrogen containing compounds can be proton donors. It all depends on the size, shape and chemical composition of the molecule as to whether the proton can be donated. Indisputable fact about the role of the B-vitamins in the body; they are proton donors while other vitamins are not. People lack energy when they are short on B-vitamins.
6. Cell water is a source of protons to the enzymes of the Krebs cycle and cell water keeps the enzymes the proper distance apart from each other. Cell water is structured water that actively participates in the enzymatic reactions of the Krebs cycle by being a source of protons, in other words, cell water is a proton donor. Hydrate2o is designed to mimic cell water in all its functions, hydration and proton donor capacity.

Xanya Sofra Weiss

Xanya Sofra Weiss

What is a hormone? Xanya Sofra Weiss

Kim D. Kelly, ND, MPH

• Cholesterol – source of all the hormones.
• Hormones play many roles in health and maintenance of body
a) Metabolism of carbohydrates, fats, minerals, proteins, water
b) Regulate DNA and RNA production
c) Regulate body’s response to stress, kidney function, blood sugar blance, menstruation and sexual
function
• As we age hormone production in body declines.

Hormonal imbalances
• Hormonal imbalances compromise not only physical health but also psychological health.
• Our body compensates for imbalances by overproducing key hormones and by converting sex
hormones to stress hormones.

Several causes of hormonal imbalance:
• Nutritional deficiencies
• Lack of exercise
• Exposure to toxins
• STRESS!
• Physiological endocrine disorders
• Sleep disorders
• Exposure to EMF
• Lack of sunlight
• Hypothyroidism
• Insulin resistance
• OTC and prescription medications

Xanya Sofra Weiss

Xanya Sofra Weiss

Blood Flow Study Suggests Other Causes For Exercise Intolerance Study In Heart Failure Patients 2006. Xanya Sofra Weiss

A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center. “Reduced tolerance for physical activity is the primary symptom of diastolic heart failure, and it greatly affects quality of life,” said Dalane Kitzman, M.D., professor of cardiology and senior researcher on the study. “This condition will increase as our population ages, so it’s important to pinpoint the reasons for their symptoms and to develop effective treatments.

Xanya Sofra Weiss

Xanya Sofra Weiss

Febrile convulsions, ataxia, developmental delay, and obesity: a new syndrome? Xanya Sofra Weiss

We describe the association of recurrent complicated febrile convulsions, developmental delay, ataxia, and obesity in three unrelated girls. The three girls, aged 3 to 4 years, were all born to healthy, nonconsanguineous parents and have normal siblings. Their birth weight was appropriate for gestational age. They are not dysmorphic and have normal head circumference. Development is delayed; they all walked with an ataxic gait after the age of 2 years and started speaking at 3 years. Their growth charts are remarkably alike: they initially had a normal growth curve and around 24 months of age started to gain weight excessively. They all continue to suffer from complicated febrile seizures, which started before 12 months of age, and are resistant to prophylactic anticonvulsants. Metabolic evaluation is normal. They have normal magnetic resonance images and electroencephalograms. Fragile X and Prader-Willi syndromes were ruled out. We suggest that this is a new mental retardation syndrome that should be considered in children with recurrent febrile convulsions, developmental delay, and obesity. In a recent study, mutations in the beta4 calcium channel were identified in the mutant epileptic mouse that presents with epilepsy, mental retardation, and ataxia. We hypothesize that a calcium channel gene may be involved in this syndrome.

Xanya Sofra Weiss

Xanya Sofra Weiss

Obesity. Xanya Sofra Weiss

Obesity is not just a cosmetic problem, but it can lead to a lot of health problems and complications. The health problems associated with obesity are diabetes, heart diseases, arthritis, stroke, liver disease, gall stones etc.

Obesity is because of eating too many calories and not getting enough physical activities to burn those calories. Excess calories are deposited in the body as fat.
Obesity increases the risk of several health problems like high blood pressure, insulin resistance, type 2 diabetes, heart diseases, stroke, gout, gallstones, colon cancer, sleep apnea and non-alcoholic fatty liver disease.

High blood pressure:
Blood vessels carry blood from heart to different organs of the body and back to heart. The blood vessels have thick but elastic walls for proper flow of blood. Decrease in elasticity of blood vessel wall increases pressure on blood passing through these vessels. Obesity decreases elasticity of blood vessels causing increase in blood pressure.

Diabetes in obesity:
Insulin is required for entry of carbohydrate into cells from the blood. The carbohydrate in cell is utilized for energy production by the cells. Excess deposition of fat in the body causes insulin resistance, because of which, insulin cannot perform its function and sugar cannot enter into cells and remain in blood. This leads to diabetes or high blood sugar. High sugar in blood leads to complications in various organs like kidney, eyes, blood vessel, and heart.

Atherosclerosis or fatty deposits in blood vessels:
Obesity is associated with increase in levels of bad cholesterol in blood. Increase cholesterol in blood causes atherosclerosis or deposition of cholesterol on the walls of blood vessels. Atherosclerosis reduces the elasticity of blood vessels, narrows blood vessels and decreases blood flow through these vessels. All these changes lead to increased risk of heart disease and stroke.

Heart diseases:
Coronary arteries are the blood vessels that supply blood to heart muscles. Atherosclerosis or fatty deposits in coronary arteries in obesity decreases blood supply to heart muscles. Decreased oxygen supply and blood flow to heart can cause angina (chest pain) and complete blockage of blood flow to heart can cause heart attack.

Stroke or paralysis:
Atherosclerosis in arteries of brain can reduce blood supply to the brain. This decrease in blood flow can result in stroke or paralysis.

Arthritis:
Obesity and overweight increases the load on the joints such as the knee, hip and lower back, which can cause the breakdown of cartilage in the joint. Cartilage is a cushion like structure in a joint required for smooth movement of joints. Breakdown of cartilage in obesity results in joint pain and stiffness and other features of osteoarthritis.

Gout:
A type of arthritis caused by the accumulation of uric acid crystals in joints. Obesity is associated with increased accumulation of these solid crystal-like masses in joints, which causes inflammation and pain.

Sleep apnea:
Overweight and excess fat around neck causes narrowing of airways and leads to sleep apnea. In sleep apnea, person snores heavily and stops breathing for short periods, which results in frequent awakening at night.

Fatty liver disease:
Obesity increases the risk of developing liver disease called fatty liver disease due to accumulation of fat in liver.

Gallbladder disease and gallstones:
Obesity increases cholesterol deposition in gall bladder, which can lead to formation of gallstones.

So, obesity can lead to a lot of health problems and other complications.
For details on role of nutrients in various diseases, please visit Diet for Disease and for information on management of obesity by blocking carbohydrate absorption, please visit
Carbohydrate in Obesity website.

Xanya Sofra Weiss

Xanya Sofra Weiss

The influence of obesity on calf blood flow and vascular reactivity in older adults. Xanya Sofra Weiss

Objective

To determine whether differences in vascular reactivity existed among normal weight, overweight, and obese older men and women, and to examine the association between abdominal fat distribution and vascular reactivity.

Methods

Eighty-seven individuals who were 60 years of age or older (age = 69 ± 7 yrs; mean ± SD) were grouped into normal weight (BMI < n =" 30)," n =" 28)," n =" 29)" p =" 0.038)" p =" 0.001)" p =" 0.006," r =" -0.44," r =" -0.37," r =" -0.36," p =" 0.001," r =" -0.32," p =" 0.002)." bmi =" weight" r =" 0.86"> 0.05) to calf blood flow obtained at rest. BMI was inversely related to the post-occlusive reactive hyperemic calf blood flow (r = -0.25, p = 0.022), and to the absolute change (r = -0.44, p < r =" -0.37," r =" -0.21," p =" 0.047)," r =" -0.36," p =" 0.001)" r =" -0.32," p =" 0.002)">

Figure 1. The relationship between body mass index and the percentage change in calf blood flow from rest to post-occlusive reactive hyperemia (r = -0.37, p <>

Figure 2. The relationship between waist circumference and percentage change in calf blood flow from rest to post-occlusive reactive hyperemia (r = -0.32, p = 0.002).

One subject had a percentage change in calf blood flow that exceeded 900%. We used two different approaches to assess whether this data point had an influence on the relationships shown in Figures 1 and 2. In the first approach, we used non-parametric procedures by calculating the Spearman Rank correlation coefficients. The percentage change in calf blood flow remained significantly related to BMI (r = -0.38, p < r =" -0.33," p =" 0.002)," r =" -0.23," p =" 0.036)," r =" -0.36," p =" 0.001)" r =" -0.28," p =" 0.014)" r =" -0.33," p =" 0.002)" r =" -0.26," p =" 0.019)">

Discussion
This investigation compared the reactive hyperemic response to three minutes of arterial occlusion in older adults having a wide range in BMI, and determined if calf blood flow differences among normal weight, overweight, and obese older adults persisted after adjusting for confounders, such as age and hypertension. The primary findings were: (1) the obese group had a blunted change in post-occlusive reactive hyperemic blood flow, indicative of impaired vascular reactivity, than the normal weight group, and (2) the difference in vascular reactivity between the obese and normal weight groups remained significant after controlling for age, hypertension and calf skinfold thickness.

The observation that obesity impairs vascular reactivity supports previous studies in young and healthy adults [8,16,21], and extends this finding to obese older adults who are free of overt cardiovascular disease. This suggests that obesity-mediated vascular dysfunction in older adults is due to impairment in endothelial function [8,16]. Our results are further supported by a report that found an inverse correlation between obesity and endothelial-independent vasodilation [22] in a small sample of older adults with diabetes. Collectively, these findings suggest that obesity has a detrimental impact on endothelial function in older adults with and without diabetes.

Besides the negative consequences of obesity on vascular function in older populations, obesity-mediated alterations in endothelial function are evident even in young adults. A lower response in endothelial-dependent vasodilation and forearm blood flow after an infusion of acetylcholine (ACh) is observed in obese, young adults compared to overweight and normal weight young adults [8]. Accumulation of abdominal fat is the primary factor for endothelial dysfunction [21]. Interestingly, endothelial function may be positively altered following a weight loss program. A prospective investigation found ACh-stimulated forearm blood flow improved following a reduction in body size and waist circumference [16]. In speculation, a program designed to decrease adiposity may improve endothelial function in older, obese adults.

The increased prevalence of chronic vascular complications consistently shown in the aging population [23,24] further complicates the association between obesity and endothelial function. The development of endothelial dysfunction and, ultimately, atherosclerosis has specifically been linked to diabetes [25], hypertension [26], and hypercholesterolemia [27], all of which increase in prevalence with advancing age [28]. Additionally, lifestyle behaviors such as physical inactivity and smoking, impair endothelial function and initiate atherosclerotic processes [23,24,29-31]. The lack of control of these co-morbid conditions leaves previous results inconclusive regarding the independent role of obesity in the pathogenesis of endothelial dysfunction. The current investigation attempted to minimize these confounding factors by excluding subjects with cardiovascular disease, diabetes, and a history of smoking during the previous year. Furthermore, vascular reactivity measurements were adjusted for group differences in age, prevalence of hypertension and calf skinfold thickness. These approaches improve the ability to determine the influence of obesity on vascular reactivity.

Finally, subcutaneous body fat, as assessed by the sum of skinfolds, did not show any relationship to blood flow or to vascular reactivity in this population. In contrast, the central distribution of adipose tissue, as assessed by waist circumference, was inversely related to vascular reactivity of these older adults. Taken collectively, these results suggest that visceral adiposity may have a more detrimental influence on vascular reactivity (i.e., endothelial dysfunction) than subcutaneous fat. Our findings are supported by a previous observation that impairment in flow-mediated, endothelium-dependent vasodilation of the brachial artery occurs with visceral obesity, rather than with subcutaneous obesity [32].

One limitation to this study is the cross-sectional design which does not establish a causal link between obesity and impaired vascular reactivity. Intervention and longitudinal studies that track changes in fat mass and vascular reactivity are necessary to better determine their association. Although we normalized the blood flow measures according to subcutaneous fat of the calf, as estimated by the calf skinfold, we did not measure intra-muscular fat. Therefore, it is possible that the difference in blood flow among the groups is partially attributed to differences in intra-muscular fat of the calf. Additionally, the measurement of vascular reactivity by the method of reactive hyperemia assesses the vasodilatory function of both the endothelium and vascular smooth muscle, and therefore is only an indirect assessment of endothelial function. The lack of physical activity measurement is another limitation to this study. Physical activity status is associated with blood flow [24] and endothelial-dependent vasodilatory function [29] and, thus, should be considered in future studies examining the influence of obesity and abdominal fat on vascular reactivity.

Although our investigation minimized confounding factors by excluding for cardiovascular disease and controlling for many primary risk factors of atherosclerosis, we did not adjust for the possible influence of secondary risk factors, such as C-reactive protein or other inflammatory markers [33,34]. Furthermore, a medical history was used to exclude participants with diagnosed cardiovascular disease and diabetes, but those with undiagnosed conditions may not have been identified. That said, the possibility exists that our self-report method of revealing existing disease does allow for an underestimated prevalence of diabetes. Lastly, our assessment of adiposity was limited to BMI and anthropometric measures rather than more precise measurements of body fat and displacement of adiposity.

In conclusion, obesity and abdominal adiposity impair vascular reactivity in older men and women, and these deleterious effects on vascular reactivity are independent of conventional risk factors. Consequently, impaired vascular reactivity may increase the risk for subsequent cardiovascular complications in older, obese adults.

Xanya Sofra Weiss

Xanya Sofra Weiss

New Treatment for Obesity. Xanya Sofra Weiss

Obesity is associated with more than 30 medical conditions including Type 2 Diabetes, Coronary Heart Disease, Osteroarthritis, High Blood Pressure, Breast Cancer, Cancers of the Esophagus and Gastric Cardia, Impaired Immune Response. Low Back Pain etc. Selim et al (2008) have shown that Obesity is related to reduced blood flow velocities in the middle cerebral arteries. Laasko et al (1990) has shown that reduced insulin-mediated glucose uptake in human obesity is due to defects in insulin’s action to increase blood flow to these tissues. Laasko et al report that this defect in insulin’s action is a novel mechanism of insulin resistance. Overall, obesity is characterized by decreased blood flow into muscle. The reduced blood flow and/or tissue activity can lead to decreased insulin-medicated glucose uptake, another factor associated with obesity according to Laasko et al (1990). Cheuk-Kwan Sun et al (2003) demosnstrated that obesity is related with reduced portal venus blood flow, and a decrease in overall hepatic perfusion and oxygenation. A clinical study with individuals presenting abnormally clumped Red Blood Cells’ (RBCs) was completed in February 2009 with a device representing the Pacemaker Technology for the Skeletal muscle (PTSM / Ion Magnum - IM). Results (see figure 1) indicate that this technology rapidly and efficiently leads to normalized erythrocytes’ separation at the microscopic level. RBCs separation is crucial for the overall blood flow and timely transport of hormones, antibodies, oxygen and nutrients to the cells, and waste products to the kidneys. Transport of Hormones is a crucial process lipolysis (T3 and Growth Hormone — GF) and muscle hypertrophy (Insulin Growth Factor - IGF-1). Additionally, erythrocyte separation resulting from treatment with the Pacemaker technology for the skeletal muscle appears to have a negative correlation with the number of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in the blood prior to the IM treatments, In summary, the erythrocyte separation resulting from treatments with the pacemaker technology for the skeletal muscle enhance hormonal transport including T3 and GH enhances hormonal transport including T3 and GH leading to lipolysis and muscle hypertrophy; 2) RBC;s separation enhances overall level of health by a significant reduction of free radicals. bacteria, fungal forms. etc.; 3) Obesity is characterized by reduced blood flow. PTSM increases RBC’s separation resulting in normalized blood flow. In conclusion, re-establishing normal levels of blood flow will not only help reduce obesity but it will help reduce the risk of heart attack as well as all other disorders associated with obesity. The fact that the Pacemaker Technology for the Skeletal muscle reduces Obesity is shown in a recent clinical study 2009. Five separate clinics from around the world participated in this clinical study . All five subjects that participated in the study showed substantial weight loss, including reduction of visceral fat. Jensen (2008) reports that an upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. The before and after of subject 3 are shown in figure 2. IM Research, the Pacemaker Technology, London University, UK Xanya Sofra-Weiss, Ph.D

The Pacemaker Technology for the Skeletal Muscle (PTSM) is a voltage driven device, very much like the Pacemaker. However, due to the complexity of the CNS, PTSM is based on a dynamic multi-sine, analogue waveform that was originally tested at the cellular level by Dr. Donald Gilbert, a molecular biologist, in the eighties. After 30 years of research, the IM was electronically engineered by the Co-Inventor of the first Pacemaker (2008) to resonate the motor nerve’s signal of strenuous exercise normally emitted by the brain. Due to its resonance with the biological signal, the PTSM signal spreads throughout the CNS inducing effortless and painless isometric and isotonic muscle contractions. The signal to the nerve ultimately triggers hormonal secretion such as Growth Hormone (GF), Thyroxine (T4) and Triiodothyronine (T3) for lipolysis and Insulin Growth Factor (IGF-1) for muscle hypertrophy.

Xanya Sofra Weiss

Xanya Sofra Weiss

Calcium homeostasis in ageing: studies on the calcium binding protein calbindin D28K. Xanya Sofra Weiss

G. Lally , R. L. M. Faull , H. J. Waldvogel , S. FerrarP, and P. C. Emson; 1997

Calbindin D28 K is a neuronal calcium binding protein which may
act as a buffer of neuronal calcium. Evidence suggests that disturbance of calcium homeostasis is important in neurodegeneration, possibly via changes in calbindin D28K. Immunoreactivity of calbindin D28 N is compared in Alzheimer's disease and age-matched controls. The size and number of calbindin D28 K positive neurons in Alzheimer's disease tissue is reduced. There is also shrinkage of the dendritic tree. Continuing work examines the function of calbindin D28 K using transgenic mice. (J Neural Transm 104:1107-1112)

Xanya Sofra Weiss

Xanya Sofra Weiss

Changes in Calcium Homeostasis during Aging and Alzheimer's Disease. Xanya Sofra Weiss

CHRISTINE PETERSON, RATIV RATAN, MICHAEL SHELANSKI, JAMES GOLDMAN; 2006

Several observations indirectly suggest that intracellular calcium regulation may be altered by aging and Alzheimer's disease. Thus, calcium homeostasis was examined directly in skin fibroblasts from Alzheimer's patients and compared to cells from normal young and elderly controls. Alterations in both bound and free calcium were noted; cells from Alzheimer's donors have higher levels of bound calcium but lower concentrations of free intracellular calcium when compared to cells from young and normal aged donors. These changes in calcium homeostasis may be physiologically significant, since processes that require transient elevations of intracellular free calcium, such as cell spreading, decline in the Alzheimer's cells. In summary, cultured skin fibroblasts from normal aged and Alzheimer's patients demonstrate deficits in calcium homeostasis and other metabolic processes when compared to cells from young donors.

Xanya Sofra Weiss

Xanya Sofra Weiss

Comparison of Apoptosis and Terminal Differentiation: The Mammalian Aging Process. Xanya Sofra Weiss

C.E. Gagna, H.-R. Kuo, E. Florea, W. Shami, R. Taormina, N. Vaswani, M. Gupta, R.Vijh, and W.C. Lambert; 2001

Apoptosis is the ordered chain of events that lead to cell destruction. Terminal differentiation (denucleation) is the process in which cells lose their nuclei but remain functional. Our group examined cell death in three tissues using two different fixatives and a postfixation procedure, involving young (5 months) and old (2 years) guinea pigs. The data reveal that B-DNA and Z-DNA content decreases, whereas single-stranded (ss-) DNA increases, in older tissues undergoing apoptosis (skin and cornea) and terminal differentiation (ocular lens). We speculate that some of the factors that contribute to the aging process might also be responsible for the enhanced amount of damaged DNA in older tissues undergoing cell death. (J Histochem 49:929–930, 2001)

Xanya Sofra Weiss

Xanya Sofra Weiss

Statins and myotoxicity: a therapeutic limitation. Xanya Sofra Weiss

Atul Tiwari, Vinay Bansal, Anita Chugh & Kasim Mookhtiar; 2006

Hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors represent the most successful class of drugs for the treatment of hypercholesterolaemia and dyslipidaemia implicated in the pathogenesis of coronary heart disease and atherosclerosis. However, the popular profile of statins in terms of efficacy has been maligned by its adverse events. The myotoxicity, ranging from mild myopathy to serious rhabdomyolysis, associated with HMG-CoA reductase inhibitors, during treatment of hypercholesterolaemia is of paramount importance. Rhabdomyolysis is a rare but idiosyncratic muscle wasting disorder of different etiologies. Statinassociated habdomyolysis causes skeletal muscle injury by self-perpetuating events leading to fatal irreversible renal damage through a series of biochemical reactions. Preferential distribution and action of statins in liver could be the key to minimise myotoxicity concerns. Hepato-specific distribution of statins is governed by various factors such as physicochemical properties, pharmacokinetic properties and selective transporter-mediated uptake in liver rather in extrahepatic cells. The interactions of statins with concomitant drugs of different classes merit attention for their safety profile. Although pharmacokinetic as well as pharmacodynamic interactions have been implicated in pathophysiology of statin-induced muscle wasting, the underlying mechanism is not clearly understood. Besides, pharmacokinetic and phramcodynamic factors, statin-associated myotoxcity may also implicate pharmacogenomic factors. The pharmacogenomics characterised by CYP polymorphism and other genetic factors is responsible for inter-individual variations to efficacy and tolerability of statins. The pathophysiological mechanisms may include statininduced differences in cholesterol:phospholipid ratio, isoprenoid levels, small GTP binding proteins and apoptosis. However, the present understanding of pathophysiological mechanisms, does not offer a reliable approach to address the same at preclinical level. Although statin-associated myotoxicity affects compliance, quality of life of patient and discontinuation rate, yet the low incidence of myotoxicty including rhabdomyolysis and less severity of commonly occurring myopathy and myalgia do not raise doubts about the clinical efficacy and tolerability of statins. Medical management of myotoxicity seems to be pivotal for the proper compliance of patients with statin treatment. The appropriate and judicious use of drugs would substantially reduce the likelihood of developing clinically important myopathy.

Xanya Sofra Weiss

Xanya Sofra Weiss

Monday, November 29, 2010

Effect of an electric stimulation facilitation program on quadriceps motor unit recruitment after stroke. Xanya Sofra Weiss

Abstract: Newsam CJ, Baker LL. Effect of an electric stimulation facilitation program on quadriceps motor unit recruitment after stroke.
Objective: To compare maximum voluntary isometric torque (MVIT) and motor unit recruitment of the quadriceps after an electric stimulation facilitation program in persons affected by cerebrovascular accident (CVA).
Design: Three-week, randomized controlled trial with an electric stimulation facilitation program added to standard care.
Setting: Inpatient rehabilitation center.
Participants: Twenty patients receiving rehabilitation for first-time CVA (51.8±15.2y; days post-CVA, 38.4±40.0d). Patients were randomly assigned to study and control groups.
Interventions: All patients received standard physical therapy (PT) care. In addition, the study
group received an electric stimulation facilitation program during weight-bearing and ambulatory activities of the PT program.
Main outcome measures: MVIT and motor unit recruitment measured by interpolated twitch testing. A 2×4
repeated-measures analysis of variance was performed on measurements at 4 intervals: pretest, 1 week, 2 weeks, and 3 weeks.
Results: MVIT increased by 77% in patients receiving electric stimulation, compared with a 31% increase for the control group. There was a significant effect for assessment time only. Motor unit recruitment increased from 35% to 53% for the study group, whereas the control group recorded no change in recruitment ability. A significant interaction was recorded, indicating improved motor unit recruitment for the study group.
Conclusions: A brief and dynamic electric stimulation facilitation program significantly improved motor unit recruitment in persons after CVA

Xanya Sofra Weiss

Xanya Sofra Weiss

Obesity and the Lung. Xanya Sofra Weiss

Chronic obstructive pulmonary disease (COPD) and obesity are common and disabling chronic health conditions with increasing prevalence worldwide. A relationship between COPD and obesity is increasingly recognised, although the nature of this association remains unknown. This review focuses on the epidemiology of obesity in COPD and the impact of excessive fat mass on lung function, exercise capacity and prognosis. The evidence for altered adipose tissue functions in obesity-including reduced lipid storage capacity, altered expression and secretion of inflammatory factors, adipose tissue hypoxia and macrophage infiltration in adipose tissue-is also reviewed. The interrelationship between these factors and their contribution to the development of insulin resistance in obesity is considered. It is proposed that, in patients with COPD, reduced oxidative capacity and systemic hypoxia may amplify these disturbances, not only in obese patients but also in subjects with hidden loss of fat-free mass. The potential interaction between abnormal adipose tissue function, systemic inflammation and COPD may provide more insight into the pathogenesis and reversibility of systemic pathology in this disease.

Xanya Sofra Weiss

Xanya Sofra Weiss

Zeta Potential and the Ability of Blood To Carry Nutrients. Xanya Sofra Weiss

Colloids are held in suspension via a very slight negative electrical charge on the surface of each particle. Like charges repel each other. This charge is called zeta potential. Blood is a colloidal solution, and all blood cells have a slight negative charge.
Zeta potential is a measure of the electrical force that exists between atoms, molecules, particles, and cells ina fluid. Zeta potential's strength determines the amount of material (nutrients, wastes) that fluids such as your blood and lymph can carry. Increasing the electrical force in the solution allows the fluid to dissolve and hold more material. In this way, more nutrients can be carried throughout your body and accumulated deposits of waste can be removed. When the zeta potential is too low, blood begins to coagulate. This is a condition known as intravascular coagulation. Blood becomes a sludge that is increasingly difficult for the heart to pump, and decreasingly effective at performing the usual functions of blood. "Blood sludge" is widespread in the population (more than half the population will die from heart problems). Intravascular coagulation is clearly visible in the blood vessels of the eye when viewed under relatively low level (60x) magnification. Blood is in constant motion at constant temperature and the pH of blood is fixed at 7.35 to 7.4, but its concentration of electrolytes is not fixed, and the electrolytes directly affect the zeta potential. "So long as the Zeta Potential (ZP) of the system remains constant, the fluidity (viscosity) of the system will also remain constant. But if the ZP of the system is progressively lowered by the introduction of cationic electrolytes or polyelectrolytes, then the stability of the system will undergo progressive changes — from simple agglomeration to fluid gel formation — and finally to a rigid gel."- Thomas M. Riddick.
One lab found that best results in reducing intravascular coagulation were obtained by drinking 8 glasses per day of water with a mix of potassium citrate and potassium bicarbonate added sufficient to raise the pH of the water to 8.0 to 8.4. The minerals MUST be taken with the water in order to be effective, because intravascular coagulation is also related to insufficient water intake. Potassium works better than sodium to reduce intravascular coagulation, in fact too much sodium in the diet is part of the problem. The lab recommends that everyone replace table salt with a mixture of 60% potassium chloride and 40% sodium chloride to better reflect the potassium/sodium balance found in foods. Forty to fifty percent of the people examined by this lab had significant blood coagulation. To increase your zeta potential you must avoid aluminum. Aluminum is used in water treatment plants to cause materials to settle out of solution. It does this by reducing the zeta potential. In your body aluminum does the same thing, causing coagulation of your blood, and deposits and plaques in your arteries, brain and throughout your body. Aluminum is found in municipally treated water, cooking utensils, vaccinations, non-clumping salt and baking powder, antiperspirants, antacids, drugs (read the label carefully), soft drinks and other canned goods where the plastic liner has cracked during sealing, and in other unexpected places. Consumption of alcohol produces intravascular coagulation. Editor's note: Alcohol also hardens the brain.The brain is a jelly, like raw egg white. To study the brain under a microscope, scientists must harden it and then they can slice it, stain it and view the slices. To harden the brain they use alcohol. As we saw in the quote from Thomas M. Riddick above, a rigid gel results from loss of zeta potential. Physicians use EDTA chelation therapy to increase zeta potential and remove toxic heavy metals from the body. The increased zeta potential allows toxic deposits in the body to re-enter solution so that they can be removed by the kidneys, liver, and in the sweat, etc. A study in Switzerland found that people who had chelation therapy to remove lead from their body also had less cancer in later years.

Xanya Sofra Weiss

Xanya Sofra Weiss

Magnetic Healing, Quackery, and the Debate about the Health Effects of Electromagnetic Fields

Roger M. Macklis; 1993

Although the biological effects of low-frequency electromagnetic radiation have been studied since the time of Paracelsus, there is still no consensus on whether these effects are physiologically significant. The recent discovery of deposits of magnetite within the human brain as well as recent, highly publicized tort litigation charging adverse effects after exposure to magnetic fields has rekindled the debate. New data suggest that electromagnetic radiation generated from power lines may lead to physiologic effects with potentially dangerous results. Whether these effects are important enough to produce major epidemiologic consequences remains to be established. The assumption of quackery that has attended this subject since the time of Mesmer's original "animal magnetism" investigations continues to hamper efforts to compile a reliable data base on the health effects of electromagnetic fields. In January 1992, lawyers for a 21-year-old Connecticut woman who had a malignant brain tumor filed the first widely recognized and authoritatively researched U.S. lawsuit charging that the tumor was the direct result of the patient's protracted exposure to the electromagnetic field (EMF) generated in a nearby power line. This case and other similar tort cases are being based in part on new suggestive evidence for adverse EMF bioeffects. Well-known investigators in the field have recently published position papers on both sides of the EMF bioeffects problem. Both sides apparently agree that the debate has been hampered by the lack of a biochemical transduction mechanism capable of explaining how low-energy magnetic fields interact with human tissue. If confirmed, the recent discovery by Kirschvink and colleagues of substantial deposits of elemental magnetite in human brain tissue may finally provide a mechanistic framework within which to analyze the epidemiologic and toxicologic data concerning EMF bioeffects. However, the sensational media coverage accorded the neural magnetite discovery and the instant skepticism and partisan hostility engendered by the magnetite announcement reflect the fact that the EMF bioeffects problem continues to be surrounded by an aura of pseudoscience, quackery, and disrepute. This article traces the history of biomagnetism and magnetic healing, concentrating on the charlatanism and quackery that have plagued the field for centuries and that may now be limiting legitimate scientific investigation by placing the field off-limits to respectable medical investigators.

Xanya Sofra Weiss

Xanya Sofra Weiss

Xanya Sofra Weiss

Arasys Inch Loss Arasys Perfector Xanya Xanya Sofra Weiss Xanya Weiss Xanya Sorfa-Weiss Xanyasofraweiss xanyaweiss perfector arasys perfectorarasys arasysperfector inch loss inch-loss body shaping Ion Magnum Pacemaker Technology pacemaker Statins Heart Disease Heart attack Diabetes obesity cellulite cellulite loss nanotechnology nanocurrent pico amperes picoamperes picocurrent marren micro current microcurrents microcurrent face lift non surgical face lift Bio-identical Hormone Therapy Bio-identical Hormones Growth Hormone Free T3 Thyroid Hormones Muscle Building Acne Reduces acne Melasma Reduces Melasma Pigmentations Reduce Pigmentation Reduce Acne

Xanya Sofra Weiss

Xanya Sofra Weiss

Electricity in the Body. Xanya Sofra Weiss

This section is important to understand because the Signalife Monitoring System detects electrical currents in the heart and should be able to detect and monitor other body parts with future applications. One should know some basics about electricity and how the human body’s phenomenon of creating electricitytakes place. Atoms of all kinds can lose or gain electrons and this changes the electrical property slightly of that atom. When you walk across a rug your body can pick up or rub off extra electrons from the rug. These electrons are now on your body and slightly change your body’s electrical potential and will need to go somewhere, so when you touch the door knob the slight electrical shock you get is the electrons leaving your body. The cells of the heart in a resting state are actually electrically polarized — that means the inside of the cell has negative electrical charge due to certain atoms of potassium, sodium, chloride and calcium which naturally have gained a few extra electrons and are therefore a bit negatively charged. The outside environment of these cells is positive — therefore you have what is called polarity (two poles having opposite properties — one negative and one positive). This difference creates an electron fl ow (like the rug example) and that is basically what electricity or electrical fl ow is all about. The cells have a membrane and the membrane has what is referred to as membrane pumps, which are actually microscopic passageways that open and close and allow some of the negative atoms in the cell to leave — changing the cell internally from negative to positive, since less negative atoms are now inside the cell.This loss of negativity is called depolarization and depolarization is the basic electrical event of the heart cells and the heart itself. As one cell depolarizes it creates a chain reaction to the cell next to it and the electrical current is on its way from one cell to another — through millions of cells in an instant. This cell to cell wave of depolarization is a fl ow of electricity, an actual electrical current and can be detected by ECG equipment. This takes less than a second to fl ow through the entire heart. Then the cells go back to normal (where the inside of the cell goes back to being negatively charged) and this process is called repolarization. Repolarization can also be detected by ECG equipment. When the cells go back to normal, it is because the membrane opens up and allows some negative atoms back in the cell. This activity of the membrane pumps (the workhorse of the cell membrane) opening and closing constantly is an amazing act of nature. Every diff erent signal and wave form shown on an ECG is a manifestation of these two processes: depolarization and repolarization.

Xanya Sofra Weiss

Xanya Sofra Weiss

A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein

Shin MK, Kim MK, Bae YS, Jo I, Lee SJ, Chung CP, Park YJ, Min do S.

The intracellular signaling events controlling human mesenchymal stem cell (hMSC) differentiation into osteoblasts are poorly understood. Collagen-binding domain is considered an essential component of bone mineralization. In the present study, we investigated the regulatory mechanism of osteoblastic differentiation of hMSC by the peptide with a novel collagen-binding motif derived from osteopontin. The peptide induced influx of extracellular Ca2+ via calcium channels and increased intracellular Ca2+ concentration ([Ca2+]i) independent of both pertussis toxin and phospholipase C, and activated ERK, which was inhibited by Ca2+/calmodulin-dependent protein kinase (CaMKII) antagonist, KN93. The peptide-induced increase of [Ca2+]i is correlated with ERK activation in a various cell types. The peptide stimulated the migration of hMSC but suppressed cell proliferation. Furthermore, the peptide increased the phosphorylation of cAMP-response element-binding protein, leading to a significant increase in the transactivation of cAMP-response element and serum response element. Ultimately, the peptide increased AP-1 transactivation, c-jun expression, and bone mineralization, which are suppressed by KN93. Taken together, these results indicate that the novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/CaMKII/ERK/AP-1 signaling pathway in hMSC, suggesting the potential application in cell therapy for bone regeneration.

Xanya Sofra Weiss

Xanya Sofra Weiss

Transient Receptor Potential Melastatin type 7 channel is critical for the survival of bone marrow derived mesenchymal stem cells. Xanya Sofra Weiss

Cheng H, Feng JM, Figueiredo ML, Zhang H, Nelson PL, Marigo V, Beck A.

The Transient Receptor Potential Melastatin type 7 channel (TRPM7) is a member of the TRP family of ion channels that is essential for cell proliferation and viability. Mesenchymal stem cells (MSCs) from bone marrow are a potential source for tissue repair due to their ability to differentiate into specialized cells. However, the role of TRPM7 in stem cells is unknown. In this study, we characterized TRPM7 in mouse MSCs using molecular biology, immunocytochemistry and patch-clamp. We also investigated TRPM7 function using a lentiviral vector and specific shRNA to knockdown gene expression. By RT-PCR and immunocytochemistry, we identified TRPM7, but not TRPM6, a close family member with similar function. Electrophysiological recordings during depletion of intracellular Mg2+ or Mg2+-ATP resulted in the development of currents typical for the channel. Furthermore, 2-aminoethoxydiphenyl borate (1 pM-100 muM) inhibited TRPM7 in a concentrationdependent manner. The molecular suppression of TRPM7 significantly decreased MSC proliferation and viability as ndetermined by MTT assay. In addition, TRPM7 gene expression was up-regulated during osteogenesis. These findings demonstrate that TRPM7 is required for MSC survival and perhaps involved in the differentiation process.

Xanya Sofra Weiss

Xanya Sofra Weiss

Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes

Aims/hypothesis The aim of the present study was to examine the relationship between chylomicron composition and expression of genes that regulate chylomicron production in the intestine. We examined expression of the following: (1) Niemann–Pick C1-like 1 (NPC1L1), which regulates cholesterol absorption; (2) ATP-binding cassette transporters G5 and G8 (ABCG5, ABCG8), which regulate cholesterol homeostasis through their ability to excrete enterocyte cholesterol back into the lumen of the intestine; and (3) microsomal triglyceride transfer protein (MTTP), which packages the chylomicron particle by assembling cholesterol, triglyceride, phospholipids and apolipoprotein B48.
Subjects, materials and methods Type 2 diabetic (26) and non-diabetic (21) patients were examined. Levels of NPC1L1, ABCG5 and ABCG8 and MTTP mRNA were measured in duodenal biopsies by real-time PCR. Lipoproteins were isolated by sequential ultracentrifugation.
Results Diabetic patients had more NPC1L1 mRNA than the control subjects (p<0.02). Expression of ABCG5 and ABCG8 mRNA was lower in the diabetic patients (p<0.05) and MTTP expression was increased (p<0.05). There was a positive correlation between NPLC1L1 and MTTP mRNA (p<0.01) and a negative correlation between NPC1L1 and ABCG5 mRNA (p<0.001). Diabetic patients on statin therapy had increased ABCG5 and ABCG8 mRNA compared to those not on statin (p<0.02 and p<0.05) and less MTTP mRNA than those not on statin (p<0.05).
Conclusions/interpretation This study demonstrates that in type 2 diabetes there are important alterations to the expression of intestinal genes that regulate cholesterol absorption and chylomicron synthesis. In diabetic patients statin therapy is associated with reduced MTTP expression and increased ABCG5 and ABCG8 mRNA. The study suggests new mechanisms to explain postprandial diabetic dyslipidaemia and the beneficial effect of statins.

Xanya Sofra Weiss

Xanya Sofra Weiss

Adipose Tissue Lymphocytes and Macrophages in Obesity and Insulin Resistance. Xanya Sofra Weiss

Obesity, and more specifically accumulation of adipose tissue in the visceral and subcutaneous abdominal locations, is a major risk factor for the development of cardiovascular pathologiesincluding hypertension and atherosclerosis, as well as metabolic disorders such as type 2 diabetes. During recent years, "metaflammation" or metabolically-triggered inflammation1 has emerged as a key process involved in the clustering of those conditions. Although several metabolically active organs such as the liver, muscle, and, recently, the intestine2 certainly play major roles, the white adipose tissue appears as a central and primary player as both a source and site of inflammation. Accumulation of adipose tissue macrophages (ATMs) has been well-described in obese conditions in mice and humans.3–5 Moreover, the ATM proinflammatoryphenotype has been linked to the development of insulin resistance in mice,4 although the exact nature of the proinflammatory myeloid cells, ie, macrophages or dentritic cells, remains to be determined.6 Nevertheless, the causal link between inflammation and insulin resistance was further strengthened by the specific knock-out of the inflammation coordinator IkappaB kinase beta of myeloid cells, which gave protection against insulin resistance.7 The study of Kintscher and al in this issue8 extends those original observations to cells of adaptative immunity. The authors suggest that the accumulation of T-lymphocytes, assessed mainly through gene expression analyses and immunohistochemistry, occurs in the perigonadal adipose tissue of mice on a high-fat diet before the accumulation of macrophages. Moreover, the increased expressionof T-lymphocyte markers was concomitant with the initiation of insulin resistance characterized by a reduction in systemic glucose tolerance and insulin sensitivity, at least compared with counterpart animals that were 5 weeks younger. Given these new findings in rodents, the authors suggest that early lymphocyte infiltration of the adipose tissue might be considered as aprimary event that orchestrates the adipose tissue inflammation (Figure). This provocative and attractive idea poses a number of questions and requires further clinical investigations tovalidate its relevance in humans.
Xanya Sofra Weiss

Xanya Sofra Weiss

Saturday, November 27, 2010

The protective efficacy of surgical latex gloves against the risk of skin contamination: how well are the operators protected? Xanya Sofra Weiss

Latex gloves are used by surgical staff to avoid exposure to patient body fluids, thus reducing the risk of contracting bloodborne viral diseases, such as hepatitis C and HIV. We studied the efficacy of the surgical barrier provided by latex gloves, before and after use in the operating theater. The electrical conductivity, insulation and mechanical resistance of glove latex were investigated, using routine supplies of surgical gloves. Latex structure was assessed by scanning electron microscopy and by mercury intrusion porosimetry. Latex is subject to hydration, a phenomenon associated in the laboratory with the loss of its electrical insulation properties. Such glove latex properties were found to be highly variable, with latex hydration times varying between 2 and more than 30 min. Rapidly hydrating gloves showed increased permeability to methylene blue, associated with higher levels of porosity. Thirty min of surgical use was associated with measurable hydration of glove latex and a statistically significant loss of electrical and mechanical resistance, with rupture load decreasing by 24%. Electronic control of the insulation properties of gloves during surgery permits early detection of hydration, and allows prompt correction by glove change, before the gloves lose their electrical and mechanical competence.

Xanya Sofra Weiss

Xanya Sofra Weiss

Massive T-Lymphocyte Infiltration into the Host Stroma Is Essential for Fibroblast Growth Factor-2-Promoted Growth and Metastasis of Mammary Tumors.

Satoshi Tsunoda*, Hiroaki Sakurai*, Yurika Saito*, Yoko Ueno*, Keiichi Koizumi* and Ikuo Saiki*

From the Division of Pathogenic Biochemistry,* Institute of Natural Medicine, and the 21st Century Center of Excellence Program, University of Toyama, Toyama; and the Pharmacokinetics and Safety Research Department, Central Research Laboratories, Kaken Pharmaceutical Company, Kyoto, Japan University of Toyama, Toyama Inflammation in the tumor stroma greatly influences tumor development. In the present study, we investigated the roles of fibroblast growth factor (FGF)-2-induced chronic inflammation in the development of 4T1 murine mammary tumors. Administration of FGF-2 into the tumor inoculation site during the initial phase of tumor growth enhanced tumor growth and pulmonary metastasis as well as microvessel density in tumor tissues in normal but not in nude mice. Infiltration of T lymphocytes and macrophages, recruitment of pericytes/vascular mural cells in neovascular walls, and the expression levels of cyclooxygenase (COX)-2 and vascular endothelial growth factor A (VEGFA) were also enhanced in the FGF-2-activated host stroma of normal mice. In addition, FGF-2-induced tumor growth and metastasis was abrogated by administration of either an immunosuppressant, FK506, or a COX-2 inhibitor. FGF-2 enhanced prostaglandin E2 secretion in cultured T lymphocytes. In addition, VEGFA secretion was increased in a co-culture of T lymphocytes and fibroblasts in vitro. These results indicate that the massive infiltration of T lymphocytes into FGF-2-activated host stroma during the initial phase of tumor growth enhances neovascular stability by regulating endogenous COX-2 and VEGFA levels because both compounds are known to play important roles in marked 4T1 mammary tumor development via FGF-2-induced inflammatory reactions.

Xanya Sofra Weiss

Xanya Sofra Weiss

Effortless Muscle Hypertrophy, Lipolysis, and Clinical Proof For Rapid and Efficient Blood Cells Separation by the Pacemaker Technology. Xanya Sofra

Xanya Sofra-Weiss, Ph.D

WHAT IS A PACEMAKER? Each individual heartbeat is actually a collection of several muscle movements spurred into action by electrical impulses. A pacemaker is a microcurrent device emitting electrical signals causing the heart muscle to begin the contractions that comprize heartbeats.

The Pacemaker Technology For the Skeletal Muscle:
A proprietary analogue waveform sends the strenuous exercise signal to the motor nerve. This strenuous exercise signal is normally emitted by the brain.
Purpose:Pacemaker Technology for the Skeletal Muscle results in effortless movement
Necessity
* Neurological Disorders
* Muscle Atrophy
* Multiple Sclerosis

Why did it take longer to Develop the Pacemaker Technology for the Skeletal Muscle than it took to
Develop the Pacemaker? Because of the involvement of the Central Nervous System and the Brain Signal must be VERY refined and in syncwith the Nervous System or it will be.

NEURO-RESONANCE:
Neuronal synapses activated out of sync with the other inputs to the neuron stand out as odd and are eliminated. Neuronal synapses that are activated in synch with other inputs to the neuron are strengthened. In this Clinical Study we used a device built by the Co-Inventor of the Pacemaker. The device emits a dynamic, multi-sine, analogue waveform originally orchestrated in London on the basis of neuromolecular biology research. This proprietary waveform resonates the motor nerve’s signal of strenuous exercise normally emitted by the brain.
Due to its resonance with the biological signal, the Special Waveform signal of the Pacemaker Technology can spread throughout the CNS. The Special Waveform Signal eventually Reaches the Brain and triggers the following chain of biological events:
1. Brain orders the pituitary to release Growth Hormone (GF), and TSH.
4. TSH is transformed into Thyroxine (T4) and Triiodothyronine (T3)
4. T3 causes lipolysis
5. GF signals the liver to release Insulin Growth Factor (IGF-1)
6. IGF-1 causes lipolysis and muscle hypertrophy. We observed that people who received Pacemaker Technology Treatments for the Skeletal Muscle reported Looking Younger and an improved sense of wellbeing. So we decided to look at their blood. Blood transports:
1. Hormones
2. Antibodies
3. Oxygen
4. Nutrients to the cells
5.Waste products to the kidneys.
METHOD: A drop of the subject’s blood was drawn from the fingertip of each subject and placed on a microscope slide. A special lens inside the microscope projected an intimate view of the living blood onto a computer screen by way of a video camera. All subjects received 6 Ion magnum treatments. There were at least 5 pictures taken from different aspects of each sample to control for the possibility of contaminating the validity and reliability of the results by selecting a certain aspect of the sample over another. This was a blind study conducted by individuals that had not been given information as to how to interpret blood samples.
RESULTS: 97% OF THE SUBJECTS HAD A VISIBLE IMPROVEMENT IN THE DEGREE OF ERYTHROCYTE SEPARATION AFTER THE FIRST TREATMENT. Erythrocyte Separation after the first treatment was on the average limited to going from Erythrocyte Aggregation to mostly Rouleau plus some round, separated, freely moving erythrocytes.
Erythrocyte Separation after the last treatment was evident in about 85% of the subjects.
1. Clinical Treatment resulted in an overall improvement in terms of normalized erythrocyte separation.
2. On the average, RBCs separation appeared to linearly improve with increased number of treatments.
3.Clinical treatment appeared to have a negative correlation with
a. fungal forms
b. poikilocytosis
c. thrombocyte aggregation
d. bacteria
4. The enhanced erythrocyte separation as well as the reduction of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria persisted during the intervals between treatments. These highly significant results suggest that the Pacemaker Technology for the Skeletal Muscle can act as a mega antioxidant by replenishing the missing electrons of free radicals thus turning them into stable molecules.

Xanya Sofra Weiss

Xanya Sofra Weiss

Study of Ionic Currents across a Model Membrane Channel Using Brownian Dynamics Biophysical Journal. Xanya Sofra Weiss

Brownian dynamics simulations have been carried out to study ionic currents flowing across a model membrane channel under various conditions. The model channel we use has a cylindrical transmembrane segment that is joined to a catenary vestibule at each side. Two cylindrical reservoirs connected to the channel contain a fixed number of sodium and chloride ions. Under a driving force of 100mV, the channel is virtually impermeable to sodium ions, owing to the repulsive dielectric force presented to ions by the vestibular wall. When two rings of dipoles, with their negative poles facing the pore lumen, are placed just above and below the constricted channel segment, sodium ions cross the channel. The conductance increases with increasing dipole strength and reaches its maximum rapidly; a further increase in dipole strength does not increase the channel conductance further. When only those ions that acquire a kinetic energy large enough to surmount a barrier are allowed to enter the narrow transmembrane segment, the channel conductance decreases monotonically with the barrier height. This barrier represents those interactions between an ion, water molecules, and the protein wall in the transmembrane segment that are not treated explicitly in the simulation.The conductance obtained from simulations closely matches that obtained from ACh channels when a step potential barrier of 2–3kTr is placed at the channel neck. The current-voltage relationship obtained with symmetrical solutions is ohmic in the absence of a barrier. The current-voltage curve becomes nonlinear when the 3kTr barrier is in place. With asymmetrical solutions, the relationship approximatesthe Goldman equation, with the reversal potential close to that predicted by the Nernst equation. The conductance first increases linearlywith concentration and then begins to rise at a slower rate with higher ionic concentration. We discuss the implications of these findings for the transport of ions across the membrane and the structure of ion channels.

Xanya Sofra Weiss

Xanya Sofra Weiss

Electricity and AIDS. Xanya Sofra Weiss

Shocking treatment proposed for AIDS.

Shocking treatment proposed for AIDS

Zapping the AIDS virus with low-voltage electric current can nearly eliminate its ability to infect humanwhite blood cells

Mentioned in: Abscess Incision & Drainage, Bone Marrow Transplantation, Complement Deficiencies
..... Click the link for more information. cultured in the laboratory, reports a research team at the Albert Einstein College of Medicine

For the engineering company, see AECOM

The Albert Einstein College of Medicine (AECOM) is a graduate school of Yeshiva University. It is a private medical school located in the Jack and Pearl Resnick Campus of Yeshiva University in the Morris Park
..... Click the link for more information. in New York City New York City: see New York, city.


New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. .

William D. Lyman and his colleagues found the exposure to 50 to 100 microamperes of electricity -- comparable to that produced by a cardiac pacemaker -- reduced the infectivity of the AIDS virus (HIV HIV(Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ) by 50 to 95 percent. Their experiments, described March 14 in Washington, D.C., at the First International Symposium on Combination Therapies, showed that the shocked viruses lost the ability to make an enzyme crucial to their reproduction, and could no longer cause the white cells to clump together -- two key signs of virus infection.

The finding could lead to tests of implantable electrical devices or dialysis-like blood treatments in HIV-infected patients, Lyman says. In addition, he suggests that blood banks might use electricity to zap HIV, and vaccine developers might use electrically incapacitated in·ca·pac·i·tate
tr.v. in·ca·pac·i·tat·ed, in·ca·pac·i·tat·ing, in·ca·pac·i·tates
1. To deprive of strength or ability; disable.

2. To make legally ineligible; disqualify. viruses as the basis for an AIDS vaccine. For scientists working to create contraceptive devices that repel sperm with electricity, the new study also hints at a lifesaving side effect: protection against HIV.

Xanya Sofra Weiss

Xanya Sofra Weiss

Incontinence and Microcurrent. Xanya Sofra Weiss

Objectives: To perform a randomized comparative study to investigate the clinical effects of extracorporeal magnetic innervation (ExMI) and functional electrical stimulation (FES) on urinary incontinence after retropubic radical prostatectomy.

Methods: Thirty-six patients with urinary incontinence after radical prostatectomy were randomly assigned to three groups (12 patients each in the FES, ExMI, and control groups). For FES, an anal electrode was used. Pulses of 20-Hz square waves at a 300-μs pulse duration were used for 15 minutes twice daily for 1 month. For ExMI, the Neocontrol system was used. The treatment sessions were for 20 minutes, twice a week for 2 months. The frequency of the pulse field was 10 Hz for 10 minutes, followed by a second treatment at 50 Hz for 10 minutes. For the control group, only pelvic floor muscle exercises were performed. Objective measures included bladder diaries, 24-hour pad weight testing, and a quality-of-life survey, at 1, 2, and 4 weeks and 2, 3, 4, 5, and 6 months after removing the catheter.

Results: The leakage weight during the 24 hours after removing the catheter was 684, 698, and 664 g for the FES, ExMI, and control groups, respectively. At 1 month, it was 72, 83, and 175 g (FES versus control, P <0.05) and at 2 months was 54, 18, and 92 g (ExMI versus control, P <0.05) in the FES, ExMI, and control groups, respectively. Finally, 6 months later, the average 24-hour leakage weight was less than 10 g in all groups. Quality-of-life measures decreased after surgery, but gradually improved over time in all groups. No complications were noted in any of the groups.

Conclusions: ExMI and FES therapies offered earlier continence compared with the control group after radical prostatectomy. We consider ExMI and FES to be recommendable options for patients who want quick improvement of postoperative urinary incontinence.

Xanya Sofra Weiss

Xanya Sofra Weiss

Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. Xanya Sofra Weiss

Alexey Kuzmenkin, Huamin Liang, Guoxing Xu, Kurt Pfannkuche, Hardy Eichhorn, Azra Fatima, Hongyan Luo, Tomo Sˇaric, Marius Wernig, Rudolf Jaenisch, and Juergen Hescheler

Several types of terminally differentiated somatic cells can be reprogrammed into a pluripotent state by ectopic expression of Klf4, Oct3/4, Sox2, and c-Myc. Such induced pluripotent stem (iPS) cells have great potential to serve as an autologous source of cells for tissue repair. In the process of developing iPS-cell-based therapies, the major goal is to determine whether differentiated cells derived from iPS cells, such as cardiomyocytes (CMs), have the same functional properties as their physiological in vivo counterparts. Therefore, we differentiated murine iPS
cells to CMs in vitro and characterized them by RTPCR, immunocytochemistry, and electrophysiology. As key markers of cardiac lineages, transcripts for Nkx2.5, MHC, Mlc2v, and cTnT could be identified. Immunocytochemical
stainings revealed the presence of organized sarcomeric actinin but the absence of mature atrial natriuretic factor. We examined characteristics and developmental changes of action potentials, as well as functional hormonal regulation and sensitivity to channel blockers. In addition, we determined expression patterns and functionality of cardiac-specific voltage- gated Na , Ca2 , and K channels at early and late differentiation stages and compared them with CMs
derived from murine embryonic stem cells (ESCs) as well as with fetal CMs. We conclude that iPS cells give rise to functional CMs in vitro, with established hormonal regulation pathways and functionally expressed cardiac ion channels; CMs generated from iPS cells have a ventricular phenotype; and cardiac development of iPS cells is delayed compared with maturation of native fetal CMs and of ESC-derived CMs. This difference may reflect the incomplete reprogramming of iPS cells and should be critically considered in further studies to clarify the suitability of the iPS model for regenerative medicine of heart disorders.—Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., Luo, H., Sˇ aric´, T., Wernig, M., Jaenisch, R., Hescheler, J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.

Xanya Sofra Weiss

Xanya Sofra Weiss